What ’ s Next For AI In Healthcare In 2023
We write tons of detailed articles about niche topics, for our seasoned audience. However, every now and then it is important to zoom out and just look at the big picture as well. Here we decided to provide a high-level outlook of what’s coming next for AI in healthcare, and hope it will be useful.
So let’s take a birds-eye view of what we can expect from AI in healthcare in the coming period. In this post, we will not discuss abstract principles but will instead focus on providing specific examples. By examining recent advancements and exploring potential future developments, we aim to provide a comprehen...
Source: The Medical Futurist - May 11, 2023 Category: Information Technology Authors: Andrea Koncz Tags: Artificial Intelligence in Medicine AI adaptive algorithm digital health AI in healthcare AI in medicine ChatGPT MedPaLM ChatGPT in healthcare AI in drug discovery Source Type: blogs
Info On What It Costs To Make Insulin API's Offshore (Courtesy of China's Gan & Lee Pharmaceuticals Ltd.)
When pharma companies refer to API ' s, they are referring to " Active Pharmaceutical Ingredients " (which is different from what an internet company means when they say API; to internet companies, the acronym API means " Application Programming Interface " ). Regardless, pharma API ' s are commonly made offshore in places like India, Malaysia, China and elsewhere because its cheaper for them and therefore helps their own bottom lines. Its unclear to me exactly how they manage issues including transporting the products across the world for some items which must be temperature-controlled, but if it fattens pharma ' s bottom...
Source: Scott's Web Log - May 1, 2023 Category: Endocrinology Tags: 2023 Biosimilar biosimilars BLA China COGS FDA Gan & Lee insulin Sandoz Source Type: blogs
Podcast Episode Recommendations: The Pulse by Wharton Digital Health with Mark Cuban and GoodRx Co-Founder Doug Hirsch
The Wharton School at University of Pennsylvania (you know, the Colonial-era Ivy League school which has a massive endowment due to the fact that the school began when Pennsylvania was still a colony back in 1740) has a health podcast. Those not in-the-know sometimes mistake University of Pennsylvania for Pennsylvania State University, which is the Keystone State ' s massive public university), so allow me set the record straight on that. The University of Pennsylvania ' s business school known as The Wharton School which is regularly ranked among the best business schools in the country and it has a price-tag to match, al...
Source: Scott's Web Log - April 27, 2023 Category: Endocrinology Tags: 2023 GoodRx mark cuban Mark Cuban Cost Plus Drug Company podcast episode recommendations The Pulse Wharton Wharton Digital Health Wharton School Source Type: blogs
Health Data Cloud Leader 1upHealth Raises $40 Million Series C led by Sixth Street Growth
Company to invest in scaling its health data platform, providing payers, providers and digital health companies with an end-to-end solution for interoperability and open computing
1upHealth today announced the close of a $40M Series C investment led by Sixth Street Growth with participation from existing investors F-Prime Capital, Jackson Square Ventures, and Eniac Ventures. 1upHealth will use this latest investment to expand product development and customer growth teams and accelerate efforts to lead the digital transformation of the healthcare industry in the cloud.
1upHealth’s FHIR®-native platform designed for inter...
Source: EMR and HIPAA - April 25, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Interoperability 1upHealth 1upHeath Data Cloud API CMS ACO Digital Transformation Eniac Ventures F-Prime Capital FHIR Health IT Funding Health IT Fundings Health IT Investment Jackson Square Vent Source Type: blogs
Aiming for Health Equity
The following is a guest article by Hakim Yadi, PhD OBE, Co-Founder and CEO at Closed Loop Medicine
Healthcare has historically taken a ‘one size fits all’ approach, which misses the ability to treat all patients as effectively and equitably as possible. Consequently, personalized medicine where treatments are better tailored to a patient has become an aspiration of the modern healthcare system. However, when we look at existing medicines used today, drug therapy is rarely dose optimized for the individual, with most therapies and medical devices approved based on overall safety and efficacy investigated in large-scale...
Source: EMR and HIPAA - April 24, 2023 Category: Information Technology Authors: Guest Author Tags: Analytics/Big Data C-Suite Leadership Health IT Company Healthcare IT Closed Loop Medicine Digital Healthcare Hakim Yadi PhD OBE Health Equity Hypertension Patient Health Outcomes Personalized Care Personalized Medicine Racial Disp Source Type: blogs
South Korea-Based Undbio Co., Ltd. + Proprietary Insulin; Maybe Biosimilars (someday)
On April 13, 2023, a South Korean biopharmaceutical company known as Undbio Co., Ltd.http://undbio.com/eng/ signed a lease with West Virginia University to build what it refers to as an insulin " manufacturing facility " in the city of Morgantown, WV (seehttps://www.wvgazettemail.com/business/undbio-planning-insulin-facility-in-morgantown/article_6b986775-6a2e-5ce5-b312-c423d79cbda2.html for more information). In all likelihood, that will be for what pharma refers to as a " fill& finish " facility, rather than one where temperature-controlled bioreactors are located.Meanwhile, a nonprofit drug company known as Civica, ...
Source: Scott's Web Log - April 24, 2023 Category: Endocrinology Tags: 2023 morgantown west virginia wv mylan biosimilar insulin undbio Source Type: blogs
Fight Aging! Newsletter, April 24th 2023
In this study, researchers show that mice lacking a functional ATF4 gene show little to no loss of grip strength and treadmill performance into late life; it is quite an impressive effect size. Assessments of muscle biochemistry do show age-related declines, but to a lesser degree than the controls. How ATF4 knockout functions to produce this outcome is an interesting question. The researchers point out a range of possible downstream and upstream targets that have been implicated in the regulation of muscle growth, but it will clearly require further work to identify the important mechanisms involved.
Aging slowly...
Source: Fight Aging! - April 23, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Lobbying Turns Green
David BoazI don ’t mean to keep writing the same article about lobbying and special interests over and over. But the federal government keeps creating more and more opportunities for special interests to hire lobbyists. This weekThe Economist writes,with up to $800bn in clean ‐energy handouts now up for grabs over the coming decade, …The energy industry as a whole spent nearly $300m last year on lobbying, the most since 2013 (see chart 1). Big oil and electric utilities, which had been reducing their spending on influence ‐seeking before 2020, haveramped it up again; spending is growing in line with that...
Source: Cato-at-liberty - April 19, 2023 Category: American Health Authors: David Boaz Source Type: blogs
An Interview with Stephanie Planque of Covalent Bioscience
Covalent Bioscience develops catalytic antibodies, a way to bind and neutralize target molecules in the body without consuming the antibody molecule itself. A given dose of catalytic antibody can thus remove many times more target molecules than is the case for standard monoclonal antibodies. This offers the potential for highly efficient removal of age-related amyloids present outside cells, perhaps the most interesting of the many possible use cases, such as those related to suppression of specific signal molecules. Like most biotech companies, the backstory behind the science emphasizes the point that progression of any...
Source: Fight Aging! - April 17, 2023 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
" The Second Request " Podcast Episode Request: Spotting Anticompetitive Conduct in Pharma Supply Chain, with 46brooklyn
The Capitol Forum is what I suppose can be called a Washington, DC-based, center-left leaning investigative news organization. In 2017, the website " Talking Biz News " (which is apparently about the news business)https://talkingbiznews.com/media-moves/whats-behind-capitol-forum-and-its-growth-plans/ operated by Chris Roush, who ' s dean of the School of Communications at Quinnipiac University (a university which happens to be a few miles away from where I grew up, so it seemed legitimate to me) described The Capitol Forum this way: " Digging deep into the connection between business and government regulation. "Anyway, The...
Source: Scott's Web Log - April 12, 2023 Category: Endocrinology Tags: 2023 46Brooklyn Research Antonio Ciaccia drug prices laissez-faire antitrust enforcement Monopoly Problems The Capitol Forum The Second Request podcast Source Type: blogs
" The Second Request " Podcast Episode Recommendation: Spotting Anticompetitive Conduct in Pharma Supply Chain, with 46brooklyn
The Capitol Forum is what I suppose can be called a Washington, DC-based, center-left leaning investigative news organization. In 2017, the website " Talking Biz News " (which is apparently about the news business)https://talkingbiznews.com/media-moves/whats-behind-capitol-forum-and-its-growth-plans/ operated by Chris Roush, who ' s dean of the School of Communications at Quinnipiac University (a university which happens to be a few miles away from where I grew up, so it seemed legitimate to me) described The Capitol Forum this way: " Digging deep into the connection between business and government regulation. "Anyway, The...
Source: Scott's Web Log - April 12, 2023 Category: Endocrinology Tags: 2023 46Brooklyn Research Antonio Ciaccia drug prices laissez-faire antitrust enforcement Monopoly Problems The Capitol Forum The Second Request podcast Source Type: blogs
Bonus Features – April 2, 2023 – 63% of nurses say AI will cause a generational divide among nursing staff, 67% of consumers prefer electronic medical bills but 78% of providers still use paper, and more
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
In this week’s edition, one story is, let’s just say, a little foolish. It is the beginning of April, after all.
News and Research
The American Telemedicine Association’s ATA Action submitted two letters to the...
Source: EMR and HIPAA - April 2, 2023 Category: Information Technology Authors: Brian Eastwood Tags: Healthcare IT AdvancedMD American Telemedicine Association ATA Atropos Health AVIA Censinet Censinet One CenTrak ChristianaCare DEA Dot2Dot DrFirst eClinicalWorks eCW Health Recovery Solutions Healthcare IT Today Bonus Feat Source Type: blogs
Enhanced Healthcare Partners Announces Growth Investment In Healthcare RCM Technology Platform Janus
Enhanced Healthcare Partners (EHP), a leading private equity firm specializing in transformative, middle-market healthcare businesses, announced today a strategic growth investment in Janus, a leading provider of healthcare revenue cycle management (RCM) technology. The new capital will fuel the company’s rapid market expansion, product development and go-to-market initiatives.
Janus helps health systems and revenue cycle service companies better understand, optimize and automate RCM workflow processes. This has resulted in a significant increase and acceleration of cash collections while lowering administrative cost...
Source: EMR and HIPAA - March 30, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Brendan Downing EHP Enhanced Healthcare Partners Health IT Funding Health IT Fundings Health IT Investment Janus Janus Health RCM Revenue Cycle Management ROI Won Park Source Type: blogs
The Business of Diabetes: 2023 Update on Glucose-Responsive Insulin
My readers may recall back in 2007, I interviewed the CEO of a startup then known as SmartCells, Inc. named Todd Zion (seehttps://blog.sstrumello.com/2007/06/conversation-with-smartcells-ceo-todd.html for my original post). In 2010, the big pharma giant Merck& Company, Inc. acquired SmartCells, Inc. (see my post athttps://blog.sstrumello.com/2010/12/merck-acquires-smartcells-inc.html for my coverage of that). For its part, Merck remained rather tight-lipped about revealing much of anything about that, although it did become the first-ever glucose responsive insulin to complete a clinical trial, which was known Merck ' ...
Source: Scott's Web Log - March 28, 2023 Category: Endocrinology Tags: Eli Lilly and Company Smart Insulin 2023 Merck Novo Nordisk SmartCells Source Type: blogs
Matthew ’s health care tidbits: The drug model for DTx was wrong
Each time I send out the THCB Reader, our newsletter that summarizes the best of THCB (Sign up here!) I include a brief tidbits section. Then I had the brainwave to add them to the blog. They’re short and usually not too sweet! –Matthew Holt
If you were to look at pharmaceuticals in the US you might make three observations. 1) They are the most important way health conditions are helped, cured or eradicated. 2) The way they are delivered to patients (via pharmacies) is very badly integrated with the health care delivery system. 3) They are way too expensive.
OK, so those are my observations not yours but I think ...
Source: The Health Care Blog - March 24, 2023 Category: Consumer Health News Authors: matthew holt Tags: Health Tech Matthew Holt digital therapeutics dtx Pear Therapeutics Source Type: blogs
